For the HCC1806 tumors, we again observed results that mirrored the tumor growth effects in Fig. 7A, where ALDH1A3 knockdown decreased the percentage of CD24−CD44+ cells in the HCC1806 tumors (Fig. 7B, center), and 2DG made this tumor reduction more significant (Fig. 7B, center). Here, ALDH1A3 is linked to neoplasm.